Search results
Results from the WOW.Com Content Network
Oxford Nanopore Technologies: 2 November 2012 [315] Nanopore sequencing: United Kingdom Sword Health: 2 November 2021 [316] ... IPO 5 United States Peloton: 4.0
Oxford Nanopore Technologies plc is a UK-based company which develops and sells nanopore sequencing products (including the portable DNA sequencer, MinION) for the direct, electronic analysis of single molecules. [2] [3] [4] It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. [5]
The London-listed firm, which was spun out from the University of Oxford and went public in 2021, expects full-year revenue to be 169 million pounds ($215.2 million), falling short of the ...
British technology company Oxford Nanopore said it hoped to reach break-even by the end of 2026, as it outlined plans to drive further growth in the life science research tools market and expand ...
For premium support please call: 800-290-4726 more ways to reach us
An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors [1] and usually also to retail (individual) investors. [2] An IPO is typically underwritten by one or more investment banks , who also arrange for the shares to be listed on one or more stock exchanges .
The observation that a passing strand of DNA containing different bases corresponds with shifts in current values has led to the development of nanopore sequencing. [14] Nanopore sequencing can occur with bacterial nanopores as mentioned in the above section as well as with the Nanopore sequencing device(s) is created by Oxford Nanopore ...
I have just modified 2 external links on Oxford Nanopore Technologies. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes: